Morphine Completed Phase 2 Trials for Allelic Frequencies of Genetic Markers / Addictions / Polymorphism-Genetic / Pain NOS Other

IndicationsStatusPurposePhase
CompletedOther2
clinicaltrials.gov IdentifierTitleDrugs
NCT01878006Genetic Effects on Dopamine Response to an Opiate